Retinopathy of Prematurity Market Players:
- Visunex Medical System
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merge Healthcare
- Natus Medical Incorporated
- Servicom Medical
- Advancing Eyecare
- Insmed Inc
- Alimera Sciences Inc.
- Biomar Microbial Technologies
- Regeneron Pharmaceuticals
- Hoffmann-La-Rochelnc
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of retinopathy of prematurity is estimated at USD 10.38 million.
The global retinopathy of prematurity market size was over USD 9.91 million in 2025 and is anticipated to witness a CAGR of around 5.3%, crossing USD 16.61 million revenue by 2035.
Across 2026–2035, the North America retinopathy of prematurity market is expected to secure a 41% share by 2035, bolstered by continuous medical technology advancements, stronger early-detection efforts, and rising adoption of AI-enabled neonatal diagnostic tools.
Key players in the market include Visunex Medical System, Merge Healthcare, Natus Medical Incorporated, Servicom Medical, Advancing Eyecare, Insmed Inc, Alimera Sciences Inc., Biomar Microbial Technologies, Regeneron Pharmaceuticals, Hoffmann-La-Rochelnc.
